CVE:COV Covalon Technologies (COV) Stock Price, News & Analysis C$3.44 0.00 (0.00%) (As of 11/4/2024 05:19 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlines About Covalon Technologies Stock (CVE:COV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Covalon Technologies alerts:Sign Up Key Stats Today's RangeC$3.40▼C$3.4450-Day RangeC$2.95▼C$3.4452-Week RangeC$0.96▼C$3.46Volume18,565 shsAverage Volume19,455 shsMarket CapitalizationC$94.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCovalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.Read More… 2 sentences that change everything you THOUGHT you knew about trading (Ad)If you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.Click here. Receive COV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address COV Stock News HeadlinesCOV:CA Covalon Technologies Ltd.October 22, 2024 | seekingalpha.comCovalon Technologies Ltd. (COV.V) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.com2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.November 5, 2024 | Investing Daily (Ad)Covalon Announces Successful Warrant Redemption from 2019 Private PlacementSeptember 23, 2024 | finance.yahoo.comCVALF Covalon Technologies Ltd.August 22, 2024 | seekingalpha.comCompare with Covalon Technologies Ltd (CVALF)August 14, 2024 | msn.comWound Healing Film Market is Projected to Reach US$ 1.18 Billion by 2034 with a 4.8% CAGR | Fact.MR ReportsAugust 14, 2024 | finance.yahoo.comClosing Bell: Covalon Technologies Ltd up on Wednesday (COV)August 8, 2024 | theglobeandmail.comSee More Headlines COV Stock Analysis - Frequently Asked Questions How have COV shares performed this year? Covalon Technologies' stock was trading at C$1.06 at the beginning of the year. Since then, COV shares have increased by 224.5% and is now trading at C$3.44. View the best growth stocks for 2024 here. How were Covalon Technologies' earnings last quarter? Covalon Technologies Ltd. (CVE:COV) announced its earnings results on Wednesday, August, 21st. The company reported $0.06 earnings per share for the quarter. The firm earned $9.22 million during the quarter. Covalon Technologies had a negative trailing twelve-month return on equity of 3.85% and a negative net margin of 2.82%. How do I buy shares of Covalon Technologies? Shares of COV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Covalon Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Covalon Technologies investors own include NIO (NIO), Reliq Health Technologies (RHT), Facedrive (FDVRF), Meta Platforms (META), NVIDIA (NVDA), Ackroo (AKR) and BeWhere (BEW). Company Calendar Last Earnings8/21/2024Today11/05/2024Next Earnings (Estimated)1/24/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:COV CUSIPN/A CIKN/A Webwww.covalon.com Phone+1-905-5688400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E Ratio11.47 P/E GrowthN/ANet IncomeC$-2,770,000.00 Net Margins-2.82% Pretax MarginN/A Return on Equity-3.85% Return on Assets-3.25% Debt Debt-to-Equity Ratio4.98 Current Ratio5.24 Quick Ratio6.45 Sales & Book Value Annual SalesC$29.20 million Price / Sales3.23 Cash FlowC$0.80 per share Price / Cash Flow4.28 Book ValueC$0.88 per share Price / Book3.91Miscellaneous Outstanding Shares27,400,000Free FloatN/AMarket CapC$94.26 million OptionableNot Optionable Beta0.64 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (CVE:COV) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Covalon Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.